BFLY vs NEOG vs GEHC Stock Comparison

Butterfly Network, Neogen and GE HealthCare Technologies Prices as of Nov 13, 2026 Peers: Industry group
BFLY Butterfly Network, Inc.
$6.09 -19.9% 1M +194.2% 1Y
Market cap
$1.53B
P/E
–
Revenue (TTM)
$123.25M
Div. yield
–
Diagnostic Equipment Healthcare
3 wins
NEOG Neogen Corp
$11.23 -7.4% 1M +76.3% 1Y
Market cap
$2.37B
P/E
–
Revenue (TTM)
$883.99M
Div. yield
–
Diagnostic Equipment Healthcare
1 win

Head to Head

10 decided of 12

GE HealthCare Technologies leads on 6 of the 12 questions below (GE HealthCare Technologies 6, Butterfly Network 3, Neogen 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBFLYNEOGGEHCLeader
Larger companyMarket capitalisation $1.53B $2.37B $37.47B GEHC
Cheaper on earningsLower P/E, profitable companies only -28.5x -42.3x 17.4x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 35.1x 16.0x GEHC
Faster revenue growthRevenue growth, trailing twelve months +39.4% -0.3% +6.9% BFLY
More profitableNet margin, trailing twelve months -43.6% -6.3% 10.0% GEHC
Better return on capitalReturn on invested capital -30.5% -0.2% 10.8% GEHC
Less leveragedLower net debt / EBITDA 2.3x 5.4x 2.0x GEHC
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +194.2% +76.3% +12.2% BFLY
Better 5-year returnAnnualised price return, 5 years -6.7%/yr -24.0%/yr — BFLY
Less volatileAnnualised volatility, 1 year 112.2% 55.6% 36.0% GEHC
Higher overall scoreMean of the five percentile scores vs peers 53/100 58/100 57/100 NEOG

Percentile Scorecard

BFLYNEOGGEHC

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBFLYNEOGGEHC
Valuation 31 #167 of 243 72 #68 of 243 86 #35 of 243
Growth 88 #28 of 228 49 #117 of 228 37 #143 of 228
Profitability 39 #137 of 222 63 #83 of 222 79 #48 of 222
Financial Health 68 #81 of 248 47 #132 of 248 27 #181 of 248
Shareholder Returns 41 #94 of 158 61 #63 of 158 57 #69 of 158
Overall 53 58 57
  • BFLY ranked among 252 companies in Medical Devices and Diagnostics
  • NEOG ranked among 252 companies in Medical Devices and Diagnostics
  • GEHC ranked among 252 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBFLYNEOGGEHCSPY
1 month -19.9%-7.4%+21.3% -2.0%
3 months -31.1%-3.6%+12.7% -2.8%
6 months +59.0%+37.1%+36.6% +2.0%
Year to date +60.3%+60.7%+1.2% +10.6%
1 year +194.2%+76.3%+12.2% +12.2%
3 years +399.2%-29.4%+15.0% +68.1%
3 years, per year +71.0%-11.0%+4.8% +18.9%
5 years -29.2%-74.6%— +61.4%
5 years, per year -6.7%-24.0%— +10.1%
10 years —-51.3%— +248.5%
10 years, per year —-6.9%— +13.3%

Risk

MeasureBFLYNEOGGEHCSPY
Volatility, 1Y 112.2%55.6%36.0% 13.6%
Downside volatility, 1Y 93.8%47.7%36.1% 13.9%
Beta vs S&P 500, 1Y 2.991.420.65 1.00
Return / volatility, 1Y 1.731.370.34 0.90
Max drawdown, 5Y -92.2%-90.6%-37.4% -25.4%
From 52-week high -38.7%-19.7%-5.8% -3.2%
52-week high $9.94$13.98$88.16 $779.14
52-week low $1.97$5.41$59.49 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBFLYNEOGGEHC
P/E now vs peer median -30.2xmedian 26.5x -43.7xmedian 26.5x 17.4xmedian 26.5x
P/S now vs peer median 13.2xmedian 2.7x 2.8xmedian 2.7x 1.7xmedian 2.7x
EV/EBITDA now vs peer median -29.5xmedian 18.4x 27.5xmedian 18.4x 12.7xmedian 18.4x
P/FCF now vs peer median -58.9xmedian 25.4x 49.2xmedian 25.4x 19.9xmedian 25.4x
P/B now vs peer median 8.8xmedian 2.5x 1.2xmedian 2.5x 3.2xmedian 2.5x
PEG now vs peer median -1.00median 0.98 1.06median 0.98 1.41median 0.98

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBFLYNEOGGEHC
Revenue $123.25M $883.99M $21.64B
Gross profit $86.60M $418.98M $8.64B
Operating income -$57.83M -$7.38M $2.89B
Net income -$53.69M -$56.10M $2.21B
Free cash flow -$27.55M $49.80M $1.89B
R&D $39.57M $19.76M $1.31B
EPS (diluted) $-0.20 $-0.26 $4.75
Cash & equivalents $122.30M $172.00M $2.86B
Total debt $2.92M $774.20M $9.97B
Shares (diluted) 266.50M 218.10M 453.00M
Enterprise value $992.96M $1.71B $25.70B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBFLYNEOGGEHC
P/E -30.2x -43.7x 17.4x
P/FCF -58.9x 49.2x 19.9x
P/Operating cash flow -69.4x 28.7x 15.5x
P/S 13.2x 2.8x 1.7x
P/B 8.8x 1.2x 3.2x
P/Tangible book 9.1x 3.1x 3.8x
EV/EBITDA -29.5x 27.5x 12.7x
EV/EBIT -26.0x -413.9x 15.5x
EV/Revenue 12.2x 3.5x 2.1x
EV/FCF -54.6x 61.3x 23.6x
EV/Operating cash flow -64.3x 35.8x 18.5x
PEG (3Y EPS CAGR) -1.00 1.06 1.41

Growth

14 metrics
MetricBFLYNEOGGEHC
Revenue growth (1Y) 39.4% -0.3% 6.9%
Revenue CAGR (3Y) 21.7% -1.3% 3.9%
Gross profit growth (1Y) 126.4% 1.8% 4.6%
Gross profit CAGR (3Y) 30.5% -3.1% 3.9%
Operating income growth (1Y) 33.5% 99.3% 5.4%
Operating income CAGR (3Y) 26.9% -29.0% 4.6%
Net income growth (1Y) 32.8% 94.6% -3.5%
Net income CAGR (3Y) 24.2% -28.3% 7.6%
EPS growth (1Y) 36.4% 94.6% -2.0%
EPS CAGR (3Y) 30.4% -41.1% 12.3%
Operating cash flow growth (1Y) 5.8% -1.9% 30.5%
Operating cash flow CAGR (3Y) 41.1% 2.9% 4.5%
Free cash flow growth (1Y) -0.1% 1,631% 34.9%
Free cash flow CAGR (3Y) 38.8% 126.1% 2.7%

Profitability

14 metrics
MetricBFLYNEOGGEHC
Gross margin 70.3% 47.4% 39.9%
EBITDA margin -41.4% 12.5% 16.2%
Operating margin -46.9% -0.8% 13.3%
Pretax margin -43.5% -7.7% 12.8%
Net margin -43.6% -6.3% 10.0%
FCF margin -22.4% 5.6% 8.7%
Operating cash flow margin -19.0% 9.6% 11.2%
Return on equity -28.7% -2.7% 19.5%
Return on assets -18.8% -1.7% 5.8%
Return on invested capital -30.5% -0.2% 10.8%
Return on capital employed -26.6% -0.2% 10.0%
Asset turnover 0.4x 0.3x 0.6x
Cash conversion (OCF / net income) 0.4x -1.5x 1.1x
Stock comp / revenue 20.8% 1.3% 0.7%

Financial Health

11 metrics
MetricBFLYNEOGGEHC
Debt / assets 1.0% 23.4% 26.0%
Debt / equity 0.0x 0.4x 0.9x
Net debt / EBITDA 2.3x 5.4x 2.0x
Debt / FCF -0.1x 15.5x 5.3x
Liabilities / assets 36.0% 36.8% 69.7%
Equity / assets 64.0% 63.2% 30.3%
Interest coverage -46.8x – 6.6x
Current ratio 3.6x 3.9x 1.3x
Quick ratio 2.3x 2.1x 0.9x
Cash ratio 1.8x 1.2x 0.3x
Altman Z-score 5.44 1.39 1.99

Shareholder Returns

7 metrics
MetricBFLYNEOGGEHC
Dividend yield – – 0.2%
Net buyback yield -0.5% -0.1% 0.7%
Shareholder yield -0.5% -0.1% 0.9%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBFLYNEOGGEHC
Forward P/E – 35.1xFY2026 16.0xFY2026
EPS, next fiscal year $-0.06FY2026 $0.32FY2026 $5.20FY2026
EPS growth, next FY – 0.0%FY2026 +13.3%FY2026
EPS growth, the year after – +31.3% -1.0%
Revenue, next fiscal year $117.62MFY2026 $847.28MFY2026 $22.63BFY2026
Revenue growth, next FY +20.5%FY2026 -2.7%FY2026 +9.7%FY2026
Revenue growth, the year after +22.7% -1.5% +7.7%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBFLYNEOGGEHC
Held by institutions 58.4% 100.0% 87.0%
Institutions holding 248 315 1,224
Change in shares held, QoQ +13.9% +1.6% +1.7%
Institutions buying 144 150 539
Institutions selling 59 106 463
Buyers to sellers 2.44 1.42 1.16

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BFLYNEOGGEHC
BFLY 1.00 0.25 0.22
NEOG 0.25 1.00 0.28
GEHC 0.22 0.28 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BFLY, NEOG and GEHC?

GE HealthCare Technologies (GEHC) is the largest by market capitalisation: Butterfly Network (BFLY) $1.53B, Neogen (NEOG) $2.37B, GE HealthCare Technologies (GEHC) $37.47B.

Which company is growing faster?

Butterfly Network (BFLY) grew revenue fastest over the trailing twelve months: Butterfly Network (BFLY) +39.4%, Neogen (NEOG) -0.3%, GE HealthCare Technologies (GEHC) +6.9%.

Which company is more profitable?

GE HealthCare Technologies (GEHC) has the highest net margin (Butterfly Network (BFLY) -43.6%, Neogen (NEOG) -6.3%, GE HealthCare Technologies (GEHC) 10.0%). On return on invested capital, GE HealthCare Technologies (GEHC) leads (Butterfly Network (BFLY) -30.5%, Neogen (NEOG) -0.2%, GE HealthCare Technologies (GEHC) 10.8%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: Butterfly Network (BFLY) +194.2%, Neogen (NEOG) +76.3%, GE HealthCare Technologies (GEHC) +12.2%. Over five years, Butterfly Network (BFLY) compounded fastest (Butterfly Network (BFLY) -6.7%/yr, Neogen (NEOG) -24.0%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, GE HealthCare Technologies (GEHC) has been the steadiest (Butterfly Network (BFLY) 112.2%, Neogen (NEOG) 55.6%, GE HealthCare Technologies (GEHC) 36.0%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BFLY, NEOG and GEHC?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, GE HealthCare Technologies (GEHC) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.